Wed, November 8, 2023

Raghuram Selvaraju Maintained (AQST) at Strong Buy with Increased Target to $6 on, Nov 8th, 2023

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Aquestive Therapeutics, Inc." (AQST) at Strong Buy with Increased Target from $5 to $6 on, Nov 8th, 2023.

Raghuram has made no other calls on AQST in the last 4 months.



There are 2 other peers that have a rating on AQST. Out of the 2 peers that are also analyzing AQST, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Raghuram


  • Andreas Argyrides of "Wedbush" Reiterated at Buy and Held Target at $4 on, Tuesday, October 10th, 2023
  • Jason Butler of "JMP Securities" Reiterated at Buy and Held Target at $8 on, Thursday, September 21st, 2023